TCL Archive DCCP Board Gives Concept Approval To RFA For Biochemical Epidemiolgy, New And Recompeting Contract Program September 23, 1983
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004